Sutro Biopharma, Inc. financial data

Symbol
STRO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
111 Oyster Point Blvd., South San Francisco, CA
Fiscal year end
December 31
Former names
Fundamental Applied Biology Inc (to 10/24/2007)
Latest financial report
10-K - Q4 2024 - Mar 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 327 % -36.6%
Debt-to-equity 326 % +75%
Return On Equity -224 % -216%
Return On Assets -52.6 % -112%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83.8M shares +34.2%
Common Stock, Shares, Outstanding 82.5M shares +35.3%
Entity Public Float 238M USD -14.6%
Common Stock, Value, Issued 83K USD +36.1%
Weighted Average Number of Shares Outstanding, Basic 76.8M shares +27.7%
Weighted Average Number of Shares Outstanding, Diluted 76.8M shares +27.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 62M USD -59.6%
Research and Development Expense 252M USD +39.7%
General and Administrative Expense 48.5M USD -22.6%
Operating Income (Loss) -238M USD -167%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -225M USD -154%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -227M USD -113%
Earnings Per Share, Basic -2.96 USD/shares -66.3%
Earnings Per Share, Diluted -2.96 USD/shares -66.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 190M USD +175%
Marketable Securities, Current 127M USD -52.1%
Accounts Receivable, after Allowance for Credit Loss, Current 8.62M USD -76.1%
Assets, Current 343M USD -18.6%
Property, Plant and Equipment, Net 18.2M USD -17.1%
Operating Lease, Right-of-Use Asset 17.7M USD -22.5%
Other Assets, Noncurrent 7.17M USD +101%
Assets 387M USD -17.7%
Accounts Payable, Current 10.5M USD +11%
Accrued Liabilities, Current 12.9M USD -12.1%
Contract with Customer, Liability, Current 69.8M USD +238%
Liabilities, Current 132M USD +40.7%
Contract with Customer, Liability, Noncurrent 12.5M USD -76.5%
Operating Lease, Liability, Noncurrent 15.7M USD -32.3%
Other Liabilities, Noncurrent 1.69M USD 0%
Liabilities 343M USD +6.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 39K USD +85.7%
Retained Earnings (Accumulated Deficit) -787M USD -40.7%
Stockholders' Equity Attributable to Parent 44.6M USD -70.2%
Liabilities and Equity 387M USD -17.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -64.7M USD -6.15%
Net Cash Provided by (Used in) Financing Activities -3.43M USD -139%
Net Cash Provided by (Used in) Investing Activities 64.1M USD -4.96%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 82.5M shares +35.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.07M USD -127%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 191M USD +173%
Interest Paid, Excluding Capitalized Interest, Operating Activities 63K USD -84%
Deferred Tax Assets, Valuation Allowance 228M USD +35.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 232M USD +28.2%
Operating Lease, Liability 23.2M USD -21.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -227M USD -114%
Lessee, Operating Lease, Liability, to be Paid 26.8M USD -25.6%
Property, Plant and Equipment, Gross 66.8M USD +4.24%
Operating Lease, Liability, Current 7.48M USD +16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.99M USD -5.65%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.53M USD +3.41%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.66M USD -43.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.29M USD -7.84%
Deferred Tax Assets, Operating Loss Carryforwards 39.7M USD +6.53%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 12.1M USD +38.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.29M USD -7.84%
Operating Lease, Payments 2.3M USD +35.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.76M USD +9.04%
Deferred Tax Assets, Net of Valuation Allowance 3.82M USD -70.8%
Share-based Payment Arrangement, Expense 24.7M USD -0.89%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%